Partin Tables update 2013: Organ confined disease
Objective was to update the 2007 Partin tables in a contemporary
patient population.
Pathological stage after radical prostatectomy can be accurately predicted by serum prostate-specific antigen level, clinical stage and biopsy Gleason sum, the ‘Partin tables’. Since the previous publication of the Partin tables, an updated Gleason scoring system has been established and incremental changes have occurred in the clinical characteristics of patients diagnosed with prostate cancer. The current analysis updates the Partin nomogram in a contemporary cohort of patients.
Research authors: John B. Eifler, Zhaoyang Feng, Brian M. Lin, Michael T. Partin, Elizabeth B. Humphreys, Misop Han, Jonathan I. Epstein, Patrick C. Walsh, Bruce J. Trock, Alan W. Partin
Details Formula Study characteristics Files & References
★★★
Model author
Model ID
734
Version
1.5
Revision date
2018-03-12
Specialty
MeSH terms
  • Prostate Cancer
  • Gleason Score
  • Prostate Specific Antigen
  • Partin Tables
  • Lymphadenectomy
  • Lymph Nodes
  • Model type
    R-Script model (Calculation)
    Status
    public
    Rating
    Share
    Formula
    No Formula defined yet
    Condition Formula

    Additional information

    The study population consisted of 5,629 consecutive men who underwent RP and staging lymphadenectomy at the
    Johns Hopkins Hospital between January 1, 2006 and July 30, 2011 and met inclusion criteria.

    Study Population

    Total population size: 5629
    Males: {{ model.numberOfMales }}
    Females: {{ model.numberOfFemales }}

    Continuous characteristics

    Name Mean SD Unit
    Age 58.5 6.66 Years
    PSA 5.8 4.35 ng/mL
    Name LL Q1 Median Q3 UL Unit
    Age 34 59 77 Years
    PSA 0.2 4.9 67.0 ng/mL

    Categorical characteristics

    Name Subset / Group Nr. of patients
    Ethnicity White 4579
    African-American 665
    Hispanic 113
    Asian 59
    Other 213
    PSA (ng/mL) 0-2.5 518
    2.6-4.0 1161
    4.1-6.0 2266
    6.1-10.0 1219
    >10 465
    Biopsy Gleason score 6 3538
    3+4 1268
    4+3 495
    8 218
    9-10 110
    Clinical stage T1c 4380
    T2a 897
    T2b 307
    T2c 45
    Prostatectomy Gleason score 6 2834
    3+4 1689
    4+3 691
    8 204
    9-10 211
    Pathological stage Organ confined 4082
    Extraprostatic extension 1277
    Seminal vesicle involvement 191
    Lymph node involvement 79

    Related files

    Supporting Publications

    The calculated risk for organ confined disease is:
    ...
    %

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Result
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    The calculated risk for organ confined disease is: %

    {{ resultSubheader }}
    {{ chart.title }}

    Outcome stratification

    Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

    Conditional information

    Result interpretation

    the current analysis represents an update of the ‘Partin tables’ based on the population of men treated from 2006 to 2011 at our institution. Pathological stage did not change between RP specimens from 2006 to 2010 and those from 2000 to 2005, possibly indicating a new equilibrium of pathological stage.Urologists may use these nomograms to predict pathological stage as a treatment decision aid for men newly diagnosed with prostate cancer.

    The confidence intervals of the prediction can be found in the table below

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    logo

    Please sign in to enable Evidencio print features

    In order to use the Evidencio print features, you need to be logged in.
    If you don't have an Evidencio Community Account you can create your free personal account at:

    https://www.evidencio.com/registration

    Printed results - Examples {{ new Date().toLocaleString() }}


    Evidencio Community Account Benefits


    With an Evidencio Community account you can:

    • Create and publish your own prediction models.
    • Share your prediction models with your colleagues, research group, organization or the world.
    • Review and provide feedback on models that have been shared with you.
    • Validate your models and validate models from other users.
    • Find models based on Title, Keyword, Author, Institute, or MeSH classification.
    • Use and save prediction models and their data.
    • Use patient specific protocols and guidelines based on sequential models and decision trees.
    • Stay up-to-date with new models in your field as they are published.
    • Create your own lists of favorite models and topics.
    A personal Evidencio account is free, with no strings attached! Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction models.

    Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.